◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksE › EMN

Eastman Chemical Company (EMN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

BASIC MATERIALS · SPECIALTY CHEMICALS · DATA UPDATED 2026-08-09

Eastman Chemical Company (EMN) operates in the SPECIALTY CHEMICALS industry and is headquartered in Kingsport, United States with about 13,000 employees. Its market capitalization is roughly $8 billion. In the fiscal year ended 2025-12-31, EMN reported $8.8B in revenue and $474M in net income.

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally.

Interactive charts & full statements → Open the EMN valuation workbench →

EMN Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$8.9B$8.8B$9.4B$9.2B$10.5B$10.5B$8.5B$9.2B$10.1B$9.5B$8.9B$9.6B$9.5B$9.4B$8.1B$7.2B$5.8B$5.0B$6.7B$6.8B$7.5B
Gross Profit$1.8B$1.8B$2.3B$2.1B$2.1B$2.5B$2.0B$2.2B$2.4B$2.5B$2.5B$2.7B$2.2B$2.8B$1.7B$1.6B$1.4B$1.0B$1.1B$1.2B$1.3B
Gross Margin %19.9%21.1%24.4%22.4%19.5%24.0%23.7%24.3%24.0%26.1%27.5%28.3%23.3%29.6%21.6%22.9%24.6%20.6%16.9%18.2%17.1%
Operating Income (EBIT)$834M$931M$1.4B$1.1B$1.1B$1.5B$1.1B$1.3B$1.5B$1.5B$1.5B$1.7B$1.3B$2.0B$948M$1.0B$846M$500M$558M$665M$673M
Operating Margin %9.4%10.6%14.7%11.9%10.3%14.0%13.3%14.3%14.5%16.1%17.2%18.0%13.4%21.0%11.8%14.2%14.6%10.0%8.3%9.7%9.0%
Net Income$442M$474M$905M$894M$793M$857M$478M$759M$1.1B$1.5B$866M$848M$751M$1.2B$437M$696M$438M$136M$346M$300M$409M
Net Margin %5.0%5.4%9.7%9.7%7.5%8.2%5.7%8.2%10.7%15.5%9.7%8.9%7.9%12.4%5.4%9.7%7.5%2.7%5.1%4.4%5.5%
EBITDA$1.3B$1.3B$1.8B$1.6B$1.6B$1.8B$1.3B$1.7B$2.1B$2.1B$1.9B$2.0B$1.6B$2.3B$1.2B$1.3B$1.0B$585M$790M$900M$989M
Earnings Per Share (EPS)$3.84$4.10$7.68$7.49$6.35$6.25$3.50$5.48$7.56$10.09$5.84$5.66$4.97$7.44$2.93$4.86$2.96$0.93$2.28$1.79$2.46
Shares Outstanding (M)115M116M118M119M125M137M136M138M143M146M148M150M151M156M149M143M148M147M152M168M167M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EMN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$2.5B$2.2B$2.0B$2.2B$2.3B$2.3B$2.2B$2.5B
Gross Profit$560M$431M$338M$433M$506M$567M$554M$605M
Gross Margin %22.3%19.8%17.1%19.7%22.1%24.8%24.7%24.6%
Operating Income (EBIT)$310M$193M$121M$210M$284M$318M$378M$357M
Operating Margin %12.3%8.9%6.1%9.5%12.4%13.9%16.8%14.5%
Net Income$183M$107M$105M$47M$140M$182M$330M$180M
Net Margin %7.3%4.9%5.3%2.1%6.1%8.0%14.7%7.3%
EBITDA$442M$316M$195M$319M$352M$432M$482M$460M
Earnings Per Share (EPS)$1.59$0.93$0.91$0.41$1.20$1.54$2.80$1.53
Shares Outstanding (M)115M115M115M115M116M118M118M118M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EMN Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$991M$970M$1.3B$1.4B$975M$1.6B$1.5B$1.5B$1.5B$1.7B$1.4B$1.6B$1.4B$1.3B$1.1B$625M$575M$758M$653M$732M$609M
Capital Expenditures (CapEx)$452M$546M$599M$828M$624M$578M$383M$425M$528M$649M$626M$652M$593M$483M$470M$466M$250M$318M$644M$529M$405M
Free Cash Flow (FCF)$539M$424M$688M$546M$351M$1.0B$1.1B$1.1B$1.0B$1.0B$759M$972M$840M$814M$658M$159M$325M$440M$9M$203M$204M
FCF Margin %6.1%4.8%7.3%5.9%3.3%9.9%12.7%11.7%10.0%10.6%8.5%10.2%8.8%8.7%8.2%2.2%5.6%8.8%0.1%3.0%2.7%
Dividends Paid$382M$381M$379M$376M$381M$375M$358M$343M$318M$296M$272M$238M$210M$140M$192M$136M$127M$128M$135M$147M$144M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EMN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$224M($137M)$502M$402M$233M($167M)$540M$396M
Capital Expenditures (CapEx)$100M$103M$112M$137M$150M$147M$175M$121M
Free Cash Flow (FCF)$124M($240M)$390M$265M$83M($314M)$365M$275M
FCF Margin %4.9%-11.0%19.8%12.0%3.6%-13.7%16.3%11.2%
Dividends Paid$96M$96M$94M$96M$95M$96M$94M$95M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EMN Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$15.4B$14.9B$15.2B$14.6B$14.7B$15.5B$16.1B$16.0B$16.0B$16.0B$15.5B$15.6B$16.1B$11.8B$11.6B$6.2B$6.0B$5.5B$5.3B$6.0B$6.2B
Cash & Cash Equivalents$691M$566M$837M$548M$493M$459M$564M$204M$226M$191M$181M$293M$214M$237M$249M$577M$516M$793M$387M$888M$939M
Total Liabilities$9.2B$8.8B$9.4B$9.1B$9.4B$9.7B$10.0B$10.0B$10.1B$10.5B$10.8B$11.6B$12.5B$8.0B$8.6B$4.3B$4.4B$4.0B$3.7B$3.9B$4.1B
Total Debt (Short + Long-Term)$765M$4.8B$5.1B$4.9B$5.2B$5.2B$5.6B$5.8B$6.2B$6.5B$6.6B$7.0B$7.5B$4.3B$4.8B$1.6B$1.6B$1.6B$1.5B$1.6B$1.6B
Total Shareholders' Equity$6.1B$6.0B$5.8B$5.5B$5.2B$5.7B$6.0B$6.0B$5.8B$5.5B$4.5B$3.9B$3.5B$3.8B$2.9B$1.9B$1.6B$1.5B$1.6B$2.1B$2.0B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EMN viewer.

Other Companies in SPECIALTY CHEMICALS

← EMMYAll “E” companiesEMND →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.